Estrogenic Regulation of Inflammation Related to TMJD

雌激素对颞下颌关节病相关炎症的调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): Our long-range goal is to identify and characterize genes through which steroidal hormones affect the onset and/or severity of human disease. The objective of this application is to determine a gene in macrophages affected by estrogen withdrawal, as seen post-partum and at menopause, that functions in immune processes. Our central hypothesis is that changes in estrogen concentrations directly regulate IgG Fc gamma receptor III-A (CD16a) expression resulting in a modulation of pro-inflammatory cytokine production and/or release from macrophages upon receptor binding. This hypothesis is based on our recent findings in vitro that 1) the level of Fc gamma RIIIA transcript increased in macrophage-like THP-1 cells and in primary, peripheral blood macrophages after estrogen removal and 2) that the observed increase was dependent on transcription. The hypothesis also includes data from another lab that binding of Fc gamma RIIIA by anti-Fc gamma RIll monoclonal antibodies stimulates macrophage TNF-alpha and IL-1 alpha release. Fc gamma RIIIA is a receptor that selectively binds IgG molecules, an important rheumatoid factor (RF) in auto-immune disease. Collectively, these data suggest that RF binding of this receptor stimulates cytokine release in rheumatoid arthritis and associated temporomandibular joint disorders (TMJD). To test our central hypothesis aim one will characterize macrophage cytokine production and release from stimulated macrophages after modulating Fc gamma RIIIA expression. TNF-alpha and IL-1 alpha will be measured after changing Fc gamma RIIIA expression levels using various estrogen and Fc gamma RIIIA antisense treatments. Aim two will focus on the mechanism inducing cytokine production and/or release upon Fc gamma RIIIA crosslinking. Signal transduction pathways and activated transcription factors will be identified as well as regulatory TNF-alpha and IL-1 alpha promoter sequences. Aim three will address the mechanism by which estrogen regulates Fc gamma RIIIA gene transcription in macrophages. The function of estrogen receptors ER alpha and/or ER beta will be directly addressed pharmacologically (e.g., antiestrogen) and through mutation studies of the Fc gamma RIIIA promoter.
描述(由申请人提供):我们的长期目标是鉴定和表征类固醇激素影响人类疾病发作和/或严重程度的基因。 本申请的目的是确定受雌激素戒断影响的巨噬细胞中的基因,如产后和绝经期所见,其在免疫过程中起作用。 我们的中心假设是雌激素浓度的变化直接调节IgG Fc γ受体III-A(CD 16 a)的表达,从而调节促炎细胞因子的产生和/或受体结合后巨噬细胞的释放。 该假设基于我们最近的体外发现,即1)去除雌激素后,巨噬细胞样THP-1细胞和原代外周血巨噬细胞中Fc γ RIIIA转录物的水平增加,2)观察到的增加依赖于转录。 的假设 还包括来自另一个实验室的数据,即抗Fc γ RIII与Fc γ RIIIA的结合 单克隆抗体刺激巨噬细胞TNF-α和IL-1 α释放。 Fc γ RIIIA是一种选择性结合IgG分子的受体,IgG分子是自身免疫疾病中的一种重要类风湿因子(RF)。 总的来说,这些数据表明,RF结合这种受体刺激类风湿性关节炎和相关的颞下颌关节疾病(TMJD)的细胞因子释放。 为了检验我们的中心假设,将表征在调节Fc γ RIIIA表达后巨噬细胞细胞因子的产生和从刺激的巨噬细胞的释放。 使用各种雌激素和Fc γ RIIIA反义治疗改变Fc γ RIIIA表达水平后,测量TNF-α和IL-1 α。 目的二将集中于在Fc γ RIIIA交联时诱导细胞因子产生和/或释放的机制。 将鉴定信号转导途径和活化的转录因子以及调节性TNF-α和IL-1 α启动子序列。 目的三将阐明雌激素调节巨噬细胞中Fc γ RIIIA基因转录的机制。 雌激素受体ER α和/或ER β的功能将被直接解决,例如,抗雌激素)和通过Fc γ RIIIA启动子的突变研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PHILLIP R KRAMER其他文献

PHILLIP R KRAMER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PHILLIP R KRAMER', 18)}}的其他基金

Estradiol and Zoster Associated Orofacial Pain
雌二醇和带状疱疹相关的口面部疼痛
  • 批准号:
    10021211
  • 财政年份:
    2019
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estradiol and Zoster Associated Orofacial Pain
雌二醇和带状疱疹相关的口面部疼痛
  • 批准号:
    10359728
  • 财政年份:
    2018
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estradiol and Zoster Associated Orofacial Pain
雌二醇和带状疱疹相关的口面部疼痛
  • 批准号:
    9905497
  • 财政年份:
    2018
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogen and TMJ Pain
雌激素和颞下颌关节疼痛
  • 批准号:
    8773730
  • 财政年份:
    2012
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogen and TMJ Pain
雌激素和颞下颌关节疼痛
  • 批准号:
    8372819
  • 财政年份:
    2012
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogen and TMJ Pain
雌激素和颞下颌关节疼痛
  • 批准号:
    8531207
  • 财政年份:
    2012
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogenic Regulation of Inflammation Related to TMJD
雌激素对颞下颌关节病相关炎症的调节
  • 批准号:
    7052843
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogenic Regulation of Inflammation Related to TMJD
雌激素对颞下颌关节病相关炎症的调节
  • 批准号:
    6881218
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogenic Regulation of Inflammation Related to TMJD
雌激素对颞下颌关节病相关炎症的调节
  • 批准号:
    6775614
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:
Estrogenic LXR Alpha Response /Cholesterol Homeostasis
雌激素 LXR Alpha 反应/胆固醇稳态
  • 批准号:
    6614747
  • 财政年份:
    2003
  • 资助金额:
    $ 25.46万
  • 项目类别:

相似海外基金

Development of a method for preserving transplanted lung function using Gapmer-type antisense nucleic acid
开发利用Gapmer型反义核酸保存移植肺功能的方法
  • 批准号:
    22K09003
  • 财政年份:
    2022
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Myostatin antisense nucleic acid therapy for rhabdomyosarcoma
肌肉生长抑制素反义核酸治疗横纹肌肉瘤
  • 批准号:
    21K07762
  • 财政年份:
    2021
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Suppression of PHOX2B (+7Ala mutant) expression by antisense nucleic acid
反义核酸抑制 PHOX2B(7Ala 突变体)表达
  • 批准号:
    20K16927
  • 财政年份:
    2020
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathogenesis and Antisense nucleic acid, glycosylation supplementation, and AAV therapy development forFukuyama muscular dystrophy and related diseases
福山性肌营养不良症及相关疾病的发病机制和反义核酸、糖基化补充以及 AAV 疗法的开发
  • 批准号:
    20H00526
  • 财政年份:
    2020
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Synthesis of antisense nucleic acid incorporating cyclic sulfonamide backbone
掺入环状磺酰胺主链的反义核酸的合成
  • 批准号:
    20K21245
  • 财政年份:
    2020
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Antisense nucleic acid splice correction therapy for Duchenne muscular dystrophy and related disorders
杜氏肌营养不良症及相关疾病的反义核酸剪接校正疗法
  • 批准号:
    G0900887/1
  • 财政年份:
    2011
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Research Grant
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID "2'-PHOSPHORYLATED RNAS" -DIRECTED TOWARD ITS BASIC STRUCTURAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
反义核酸新材料“2-磷酸化RNAS”的化学合成-针对其基础结构研究和HIV病毒表达调控-
  • 批准号:
    05558090
  • 财政年份:
    1993
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)
CHEMICAL SYNTHESIS OF A NEW MATERIAL OF ANTISENSE NUCLEIC ACID"2"PHOSTHORYLATEDRNAS" DIRETED TOWARD IIS BASIC STRUCTRAL STUDIES AND REGULATION OF EXPRESSION OF HIV VIRUS-
针对 IIS 基础结构研究和 HIV 病毒表达调控的反义核酸新材料“2”磷酸化 RNA 的化学合成-
  • 批准号:
    04453031
  • 财政年份:
    1992
  • 资助金额:
    $ 25.46万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了